Lars Ismail is an experienced medical professional currently serving as an Assistenzarzt in surgery at Universitäts Klinikum Heidelberg since October 2019. Additionally, Lars has been involved in a promotion role at the National Center for Tumor Diseases (NCT) Heidelberg since October 2016. Prior to these positions, Lars worked as a Senior Statistician at HealthEcon. Educational qualifications include a Staatsexamen in Medicine from Heidelberg University (2012-2019), a Master of Science in Mathematics and Statistics from The University of Edinburgh (2010-2011), and a Bachelor of Science in Economics from The University of Bonn (2008-2010).
This person is not in the org chart
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.